Caplin Point Laboratories Ltd

BOM:524742 (India)  
₹ 1935.35 (+1.71%) Sep 24
30.85
P/B:
6.35
Market Cap:
₹ 147.11B ($ 1.76B)
Enterprise V:
₹ 139.25B ($ 1.67B)
Volume:
7.17K
Avg Vol (2M):
24.57K
Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Caplin Point Laboratories Ltd ( ) from 2001 to Sep 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Caplin Point Laboratories stock (BOM:524742) PE ratio as of Sep 25 2024 is 30.85. More Details

Caplin Point Laboratories Ltd (BOM:524742) PE Ratio (TTM) Chart

To

Caplin Point Laboratories Ltd (BOM:524742) PE Ratio (TTM) Historical Data

Total 1244
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Caplin Point Laboratories PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-25 30.9 2024-07-23 23.6
2024-09-24 30.9 2024-07-22 23.5
2024-09-23 30.3 2024-07-19 23.9
2024-09-20 30.9 2024-07-18 24.3
2024-09-19 30.6 2024-07-16 24.4
2024-09-18 31.3 2024-07-15 24.2
2024-09-17 32.0 2024-07-12 24.2
2024-09-16 31.2 2024-07-11 24.2
2024-09-13 30.7 2024-07-10 24.5
2024-09-12 31.4 2024-07-09 24.1
2024-09-11 31.3 2024-07-08 22.6
2024-09-10 32.0 2024-07-05 23.3
2024-09-09 32.0 2024-07-04 22.8
2024-09-06 32.0 2024-07-03 22.8
2024-09-05 33.7 2024-07-02 23.1
2024-09-04 31.4 2024-07-01 23.1
2024-09-03 30.8 2024-06-28 23.5
2024-09-02 30.0 2024-06-27 24.6
2024-08-30 30.4 2024-06-26 23.0
2024-08-29 28.6 2024-06-25 23.4
2024-08-28 29.4 2024-06-24 23.7
2024-08-27 31.1 2024-06-21 23.7
2024-08-26 29.4 2024-06-20 23.6
2024-08-23 27.8 2024-06-19 23.3
2024-08-22 28.3 2024-06-18 23.3
2024-08-21 28.1 2024-06-14 23.0
2024-08-20 28.3 2024-06-13 23.3
2024-08-19 29.4 2024-06-12 24.4
2024-08-16 25.3 2024-06-11 24.3
2024-08-14 24.9 2024-06-10 24.6
2024-08-13 25.0 2024-06-07 22.8
2024-08-12 24.8 2024-06-06 21.7
2024-08-09 23.9 2024-06-05 21.6
2024-08-08 23.6 2024-06-04 20.7
2024-08-07 25.2 2024-06-03 21.5
2024-08-06 24.6 2024-05-31 21.5
2024-08-05 24.6 2024-05-29 21.8
2024-08-02 26.1 2024-05-28 21.5
2024-08-01 25.3 2024-05-27 21.6
2024-07-31 25.1 2024-05-24 21.7
2024-07-30 24.8 2024-05-23 21.8
2024-07-29 24.8 2024-05-22 21.5
2024-07-26 24.3 2024-05-21 21.5
2024-07-25 24.0 2024-05-17 22.3
2024-07-24 24.2 2024-05-16 22.8

Caplin Point Laboratories Ltd (BOM:524742) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.